Showing results (1541-1550 of 3,408) with videos related to
Sort By:
Pageof 341
Immunological Reviews|February 16, 2008
Signal initiation in T-cell receptor microclustersMaria-Cristina Seminario, Stephen C BunnellImmunological Reviews|February 16, 2008
Making friends in out-of-the-way places: how cells of the immune system get together and how they conduct their business as revealed by intravital imagingRonald N Germain, Marc Bajénoff, Flora Castellino, et al.Immunological Reviews|February 16, 2008
Decoding the dynamics of T cell-dendritic cell interactions in vivoSusanna Celli, Zacarias Garcia, Hélène Beuneu, et al.Immunological Reviews|March 5, 2017
TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapyYemsratch T Akalu, Carla V Rothlin, Sourav GhoshImmunological Reviews|March 5, 2017
The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3Murali Janakiram, Urvi A Shah, Weifeng Liu, et al.Immunological Reviews|March 5, 2017
TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapyWilliam C Dougall, Sema Kurtulus, Mark J Smyth, et al.Immunological Reviews|March 5, 2017
Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapyLeslie S Kean, Laurence A Turka, Bruce R BlazarImmunological Reviews|March 5, 2017
The CD47-SIRPα signaling axis as an innate immune checkpoint in cancerHanke L Matlung, Katka Szilagyi, Neil A Barclay, et al.Immunological Reviews|December 1, 1987
Interactions between the neuroendocrine and immune systems: common hormones and receptorsD A Weigent, J E BlalockImmunological Reviews|August 1, 1986
The interleukin-2 receptor, its physiology and a new approach to a selective immunosuppressive therapy by anti-interleukin-2 receptor monoclonal antibodiesT Diamantstein, H OsawaPageof 341